1037 related articles for article (PubMed ID: 10510318)
21. Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers.
Amai K; Fukami T; Ichida H; Watanabe A; Nakano M; Watanabe K; Nakajima M
Drug Metab Pharmacokinet; 2020 Dec; 35(6):539-547. PubMed ID: 33036882
[TBL] [Abstract][Full Text] [Related]
22. Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.
Bains OS; Grigliatti TA; Reid RE; Riggs KW
J Pharmacol Exp Ther; 2010 Dec; 335(3):533-45. PubMed ID: 20837989
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
24. Cloning and expression of succinic semialdehyde reductase from human brain. Identity with aflatoxin B1 aldehyde reductase.
Schaller M; Schaffhauser M; Sans N; Wermuth B
Eur J Biochem; 1999 Nov; 265(3):1056-60. PubMed ID: 10518801
[TBL] [Abstract][Full Text] [Related]
25. A novel aldo-keto reductase from Escherichia coli can increase resistance to methylglyoxal toxicity.
Grant AW; Steel G; Waugh H; Ellis EM
FEMS Microbiol Lett; 2003 Jan; 218(1):93-9. PubMed ID: 12583903
[TBL] [Abstract][Full Text] [Related]
26. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
Hayes JD; Judah DJ; Neal GE
Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
28. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
Burczynski ME; Lin HK; Penning TM
Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
[TBL] [Abstract][Full Text] [Related]
29. Purification, molecular cloning, and catalytic activity of Schizosaccharomyces pombe pyridoxal reductase. A possible additional family in the aldo-keto reductase superfamily.
Nakano M; Morita T; Yamamoto T; Sano H; Ashiuchi M; Masui R; Kuramitsu S; Yagi T
J Biol Chem; 1999 Aug; 274(33):23185-90. PubMed ID: 10438489
[TBL] [Abstract][Full Text] [Related]
30. Characterization of recombinant YakC of Schizosaccharomyces pombe showing YakC defines a new family of aldo-keto reductases.
Morita T; Huruta T; Ashiuchi M; Yagi T
J Biochem; 2002 Oct; 132(4):635-41. PubMed ID: 12359080
[TBL] [Abstract][Full Text] [Related]
31. The high resolution crystal structure of rat liver AKR7A1: understanding the substrate specificites of the AKR7 family.
Kozma E; Brown E; Ellis EM; Lapthorn AJ
Chem Biol Interact; 2003 Feb; 143-144():289-97. PubMed ID: 12604215
[TBL] [Abstract][Full Text] [Related]
32. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.
Crosas B; Hyndman DJ; Gallego O; Martras S; Parés X; Flynn TG; Farrés J
Biochem J; 2003 Aug; 373(Pt 3):973-9. PubMed ID: 12732097
[TBL] [Abstract][Full Text] [Related]
33. Identification, cloning and characterization of an aldo-keto reductase from Trypanosoma cruzi with quinone oxido-reductase activity.
Garavaglia PA; Cannata JJ; Ruiz AM; Maugeri D; Duran R; Galleano M; García GA
Mol Biochem Parasitol; 2010 Oct; 173(2):132-41. PubMed ID: 20595031
[TBL] [Abstract][Full Text] [Related]
34. Structure and tissue-specific expression of the aldo-keto reductase superfamily.
Qin KN; Cheng KC
Biochemistry; 1994 Mar; 33(11):3223-8. PubMed ID: 7511002
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1.
Alzeer S; Ellis EM
Biochem Pharmacol; 2014 Dec; 92(3):499-505. PubMed ID: 25256836
[TBL] [Abstract][Full Text] [Related]
36. High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver.
Breyer-Pfaff U; Nill K
Biochem Pharmacol; 2000 Feb; 59(3):249-60. PubMed ID: 10609553
[TBL] [Abstract][Full Text] [Related]
37. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase.
Ellis EM; Hayes JD
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):535-41. PubMed ID: 8526867
[TBL] [Abstract][Full Text] [Related]
38. Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin.
Sheng X; Parmentier JH; Tucci J; Pei H; Cortez-Toledo O; Dieli-Conwright CM; Oberley MJ; Neely M; Orgel E; Louie SG; Mittelman SD
Mol Cancer Res; 2017 Dec; 15(12):1704-1713. PubMed ID: 29117945
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of rat liver 3α-hydroxysteroid dehydrogenase and identification of structurally related proteins from rat lung and kidney.
Cheng KC
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1083-8. PubMed ID: 22217852
[TBL] [Abstract][Full Text] [Related]
40. Cloning and expression of two novel aldo-keto reductases from Digitalis purpurea leaves.
Gavidia I; Pérez-Bermúdez P; Seitz HU
Eur J Biochem; 2002 Jun; 269(12):2842-50. PubMed ID: 12071946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
